UKIBCS

Breast Cancer Research Foundation

The Breast Cancer Research Foundation is a nonprofit organization committed to achieving prevention and a cure for breast cancer. We provide critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship.

Platinum Sponsors

AstraZeneca

AstraZeneca has been developing cancer medicines for more than 40 years. We aim to improve cancer survival rates in UK and around the world. Even as R&D continues to push boundaries in how we understand and fight cancer, there is still more to do.

We are at the heart of oncology R&D in the UK and are committed to advancing the science of oncology to deliver life-changing medicines. Our ambition is to eliminate cancer as a cause of death through scientific discovery and collaborations and ensure that these reach people in most need.

Our UK mission is focused on three core areas – ensuring early patient identification and diagnosis, keeping pace with science and optimising cancer care pathways – and is underpinned by our commitment to patient experience, digital transformation, collaboration with the UK life sciences community and a diverse and innovative culture.

Daiichi-Sankyo

More information to follow shortly.

Exact Sciences

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier.

Building on the success of the Oncotype DX Breast Recurrence Score® Test and the Cologuard® stool DNA-based colorectal cancer screening test¹, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis.

We serve patients in more than 90 countries and our Oncotype DX® test is the most commonly used genomic assay in the NHS for adjuvant chemotherapy treatment decision-making for patients with early-stage HR+, HER2- breast cancer. To learn more, please come along to Stand 09 where we will be happy to tell you more about what we do.

1. This product is only available in the US

Lilly Oncology

Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

At Lilly, we are dedicated to developing and delivering innovative medicines that will make a meaningful difference to cancer patients. For us, this means putting an intense focus on the latest scientific advances and collaborating with doctors, other researchers, advocates and payers to ensure our medicines bring value to people living with cancer.

People living with cancer are at the centre of what we do. We believe health care makes a difference when striving to improve peoples’ lives. Whether it's treating rare tumour types, leveraging precision medicine, continuing the study of immuno-oncology or discovering new ways to advance existing treatments, we're dedicated to making even greater differences in the lives of people living with cancer.

To learn more about Lilly, please visit us at www.lilly.co.uk.

MSD

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines.

We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.

We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

For more information, visit www.msd.com and connect with us:

Novartis

At Novartis, our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues and we work together with the system to implement solutions that drive access for UK patients. From research to delivery, we are a valued partner in the healthcare ecosystem, supporting in times of crisis and beyond, to build solutions that provide better care and access opportunities for every patient in the UK.

Discovering new treatments requires imagination and visionary thinking combined with determination and rigour. This happens every day at Novartis. We are proud of our contribution to medical progress, but there’s still a long way to go. Through the discovery, research and development of innovative treatments and technologies, we aim to tackle devastating diseases and help people in the UK and around the world live longer, better lives. For more information, please visit us at www.novartis.com/uk-en/.

Gold+ Sponsor

Gilead Oncology

Creating the future of oncology to help bring more life to people with cancer.

For more than 30 years, Gilead has pursued and achieved breakthroughs in medicine that were once thought impossible. At Gilead, we’re committed to advancing innovative therapeutics for people with life-threatening diseases.

Gilead Oncology sees the impact cancer has across the UK and Ireland, and our determination to transform cancer treatment builds on our achievements of driving innovation and revolutionising the treatment of other diseases.

Gilead has approved products for both haematological malignancies and solid tumours and an extensive clinical development programme.

Visit https://www.gilead.co.uk/ for more information.

Gold Sponsors

Menarini Stemline

At Menarini Stemline, we are committed to developing a broad pipeline of innovative, transformative therapies in oncology and making a difference in cancer patients’ lives.

We invest in developing precision medicine through our pipeline of investigational drugs and partner with cancer experts and research institutions globally.

Roche

At Roche UK, we focus our energy and investment in developing tests and treatments that change lives and give us more quality time with the people we love. And, together with others, we’re solving healthcare’s greatest challenges; helping to achieve better results by connecting early diagnosis to targeted treatment and ongoing support.

Healthcare matters to all of us. That’s why we work hard to ensure that all our new medicines are made available to those who need them through the NHS - wherever they live, whatever their circumstances.

In 2020, more than 820 million Roche diagnostic tests were used to confirm, rule out or manage health conditions and over 712,000 patients benefited from our medicines and diabetes monitoring and insulin delivery system. During this period, we contributed £1.26 billion to the UK economy, supporting over 21,000 jobs.

Proud of what we do, we’re here because we care. In the UK we employ over 2,000 brilliant specialists who work together to transform the lives of patients and their loved ones. That’s what makes us who we are.

That’s what makes us Roche UK. For more information, please visit www.roche.co.uk.

Veracyte

Veracyte is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer.

Our high-performing tests enable clinicians to make more confident diagnostic, prognostic, and treatment decisions for some of the most challenging diseases such as thyroid, prostate, breast, bladder and lung cancers, as well as interstitial lung diseases.

We help patients avoid unnecessary procedures and speed time to diagnosis and appropriate treatment. In addition to making our tests available in the U.S. through our central laboratories, our exclusive license to a best-in-class diagnostics instrument (the nCounter Analysis System) positions us to deliver our tests to patients worldwide through laboratories that can perform them locally. Veracyte is based in South San Francisco, California.

For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).

2024 Supporters